Cumberland Pharmaceuticals shares are trading higher after the company announced that Apotex will acquire its line of branded pharmaceuticals for $100 million.

Benzinga Newsdesk www.benzinga.com Positive 94.9%

Neg 0% Neu 0% Pos 94.9%

Comments

No comments yet. Be the first!